Clinical Trial

One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease

Name: One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease — clinical trial record (NCT07431437)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the long-term safety and efficacy of GENOSS PCB by enrolling and tracking patients who underwent percutaneous transluminal angioplasty using GENOSS PCB in patients with femoropopliteal artery disease.

Trial Details

NCT Number	NCT07431437
Lead Sponsor	Genoss Co., Ltd.
Conditions	PTA (Percutaneous Transluminal Angioplasty), Femoropopliteal Artery Disease
Enrollment	300 participants
Start Date	2025-06-17
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-24